A 153
Pill imprint A 153 has been identified as Nifedipine extended release 30 mg.
Nifedipine is used in the treatment of high blood pressure; raynaud's syndrome; angina pectoris prophylaxis; migraine prevention; hypertrophic cardiomyopathy (and more), and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy.
Nifedipine 30 mg is not subject to the Controlled Substances Act.
See also related documents.
Nifedipine extended release Images
- Imprint:
-
A
153 - Strength:
- 30 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
hypromelloses
lactose monohydrate
magnesium stearate
polydextrose
polyethylene glycol 8000
triacetin
ferric oxide yellow
titanium dioxide
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Actavis
- National Drug Code (NDC):
- 67767-0153
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0142 | Amerisource Health Services |
| 63739-0451 | McKesson Packaging Services |
| 67544-1136 | Prepak Systems Inc (repackager) |
| 21695-0908 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Submitted by: jdidi
Advertisement
More Nifedipine Extended Release resources
- Nifedipine
- Nifedipine (Wolters Kluwer)
- Nifedipine Sustained-Release Tablets (Wolters Kluwer)
- nifedipine (Cerner Multum)
- nifedipine (Micromedex) - Includes Dosage Information
- Nifedipine (AHFS DI)
- Nifedipine Capsules (FDA)
- Nifedipine Extended-Release Tablets (FDA)
- Nifedipine (Wolters Kluwer)
Search Again
